Page 78 - FBL AR 2019-20
P. 78
Fermenta Biotech Limited
Annual Report 2019-20
Annexure III
CORPORATE GOVERNANCE REPORT
COMPANY’S PHILOSOPHY ON CODE OF GOVERNANCE
Your Company firmly believes that corporate governance is a key element in improving efficiency and growth as well as enhancing investors’
confidence. The Company constantly strives towards betterment of aspects such as transparency, professionalism and accountability and
thereby perpetuate it into generating long term economic value for its shareholders, customers, employees, other associated persons and
the society at large. The Company is committed to good corporate governance in line with the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). The Board of Directors of your Company reviews
corporate governance norms from time to time and recommends implementation thereof.
BOARD OF DIRECTORS
The Board of Directors of the Company has an optimum combination of executive and non-executive Directors as stipulated under Regulation
17 of the Listing Regulations. The Chairman of the Board is an Independent Director. The Board of Directors confirm that the Independent
Directors fulfill the conditions specified in terms of Schedule V of Regulation 34(3) of the Listing Regulations. The composition of the Board
as on March 31, 2020 is as follows:
Name of Director Category Directorships Chairmanship Membership Name of other
in all other in other in other Listed entities in
companies Committees Committees which the Director
in all other in all other holds Directorship
companies companies and the Category of
such Directorship
Mr. Sanjay Buch Chairman (Independent 5 NIL NIL NIL
(DIN: 00391436) Director)
Ms. Rajeshwari Datla* Non Executive Director 2 NIL NIL NIL
(DIN: 00046864)
Mr. Vinayak Hajare Independent Director 7 NIL NIL NIL
(DIN: 00004635)
Mr. Krishna Datla * Managing Director 5 NIL NIL NIL
(DIN: 00003247)
Mr. Satish Varma Executive Director 4 NIL NIL NIL
(DIN: 00003255) (w.e.f. September 27, 2019)
Dr. Gopakumar Nair Independent Director 2 2 2 Sequent Scientific
(DIN: 00092637) Limited
(Chairman,
(Independent
Director)
Ms. Anupama Datla Desai* Executive Director 2 NIL NIL NIL
(DIN: 00217027) (w.e.f. September 27, 2019)
Ms. Rajashri Ojha Additional (Independent) 1 NIL NIL NIL
(DIN: 07058128)** Director
None of the Directors hold office of directorship in any other listed entities.
* Mr. Krishna Datla is one of the Promoters of the Company. Ms. Rajeshwari Datla and Ms. Anupama Datla Desai are relatives of Mr. Krishna Datla as per the provisions
of Section 2(77) of the Companies Act, 2013.
** Appointed w.e.f. April 1, 2020.
76